Related Experiment Video
Updated: May 29, 2026
09:37
A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Genetic polymorphisms of animal complement components.
1MRC Human Biochemical Genetics Unit, Galton Laboratory, University College, London, UK.
Experimental and Clinical Immunogenetics
|January 1, 1988
Summary
This review explores complement polymorphisms in animals, highlighting their value as genetic markers for evolutionary and biomedical studies. It emphasizes protein-based data and discusses future research directions in animal complement genetics.
Area of Science:
- Immunogenetics
- Comparative Genomics
Background:
- Current knowledge on complement polymorphisms in non-human vertebrates is reviewed.
- Focus is on protein studies due to limited DNA data in animal complement genetics.
- Complement components are highly polymorphic, offering value as genetic markers.
Purpose of the Study:
- To summarize current knowledge of complement polymorphisms in non-human vertebrates.
- To explore the evolutionary, structural, and regulatory aspects of complement genes.
- To discuss the practical applications of complement component variation in genetics, biomedicine, and veterinary science.
Main Methods:
- Review of existing literature on animal complement genetics.
- Tabular summarization of data on animal complement component polymorphisms.
- Discussion of evolutionary implications derived from polymorphism data.
Main Results:
- Animal complement genetics data is primarily derived from protein studies.
- Complement components exhibit significant polymorphism across vertebrate species.
- Polymorphisms serve as valuable genetic markers with evolutionary and practical implications.
Conclusions:
- Comparative genetic studies of complement offer insights into evolution and gene regulation.
- Animal complement polymorphisms have significant potential as genetic markers.
- Future research should expand comparative studies on animal complement variation.
More Related Videos
Related Concept Videos
00:49Complementation Tests
A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:27Complement System
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...